Clinical Trials Directory

Trials / Completed

CompletedNCT04758364

Factors That Effect the Gait Speed in Diabetic Individuals Without Neuropathy

Status
Completed
Phase
Study type
Observational
Enrollment
71 (actual)
Sponsor
GULIN FINDIKOGLU · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study planned to investigate the role of potential explanatory factors effecting the speed of gait such as muscle mass, aerobic capacity, physical activity status, cognitive function, blood pressure, and metabolic measures considering age, sex, and education years in diabetic individuals without neuropathy.

Detailed description

Type 2 diabetic people will be screened by clinical symptoms of neuropathy and DN4 questionnaire. Among those who did not have neuropathic symptoms or who have DN4 score below 4 will be considered for the study.Then aerobic capacity will be measured by a cycle ergometer and VO2max will be obtained. Weight, body mass index and muscle mass will be measured by bioimpedance analysis. Physical activity status will be determined by International Physical Activity Score (IPAQ). Cognitive function will be evaluated by Mini Mental test. HbA1c and fasting blood glucose will be measured in venous blood after overnight fasting. Blood pressure will be measured in the sitting position after resting from the left arm. Speed of gait will be measured by an accelerometer.Then, the effect of above mentioned factors on speed of gait will be studied.

Conditions

Interventions

TypeNameDescription
OTHERmeasurement of gait speedCross sectional, cohort

Timeline

Start date
2021-02-20
Primary completion
2021-03-12
Completion
2021-03-30
First posted
2021-02-17
Last updated
2021-04-01

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04758364. Inclusion in this directory is not an endorsement.